ERBB2 and breast cancer: Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2‐Positive Breast Cancer ‐ A Collaborative Study of NRG Oncology and KROG